Extract
The phenylalanine hydroxylase assay was modified by using biopterin, Iysolecithin, and dithioerythritol. Liver tissue was obtained by percutaneous needle biopsies in patients with phenylketonuria ( P K U ) and hyperphenylalaninemia. The use of the naturally occurring cofactor biopterin is essential to measure low enzyme activities. Thirteen of 14 assay specimens in which no activity was detectable correlated with the clinical picture of classic P K U . Twelve assay specimens showed a residual activity up to 6% of normal. This group comprises patients with classic P K U and with so-called hyperphenylalaninemia. Four specimens ranged between 8.7 and 34.5% of the normal values. Patients in this group have developed normally so far without dietary treatment. I t seems that patients with residual activity tolerate more phenylalanine in the diet than patients with no detectable activity. One infant with biochemical symptoms of classic P K U was found to have a normal phenylalanine hydroxylase activity.
Speculation
The variety of enzyme activities may reflect individual defects within the enzyme molecule. The clinical picture of P K U may not necessarily involve a defect of the phenylalanine hydroxylase in each -UTZ, A N D BICKEL case. The determination of the phenylalanine hydroxylase activity together with the biochemical parameters hitherto used might contribute to the differential diagnosis of PKU-hyperphenylalaninemia.
Phenylalanine hydroxylase (EC. 1.14.3. I) was first shown to be deficient in patients with P K U by Udenfriend and Cooper (16) . and this was confirmed by Jervis (7) . The complexity of the phenylalanine hydroxylation system was elucidated mainly by Kaufman (10) and by La Du and Zannoni (13) .
Classic P K U (18) requires early dietary treatment to prevent mental retardation. Hyperphenylalaninemia, a condition which simulates P K U biochemically, is believed by most authors not to cause retardation or to need therapy. The differential diagnosis and decision regarding treatment are based on biochemical parameters. some of which are still ambiguous. An additional parameter of diagnostic value might be the determination of phenylalanine hydroxylase. S o Far only a few reports are available in which enzyme activity was measured in P K U and variant patients (6, 8, 9) .
MATERIALS A N D METHODS
Liver needle biopsies were kindly performed by Dr. D. Feist.
The tissue (10-30 mg) was frozen immediately in liquid nitrogen and kept frozen at -70' for 1 -4 weeks before use. L-Phenylalanine was purchased from Merck, Germany. "C-labeled Lphenylalanine from New England Nuclear Co., lysolecithin was obtained from K. Roth, Germany, and dithioerythritol from Serva, Germany. Tetrahydrobiopterin was generously given to us by Professor Pfleiderer. Konstanz, Germany.
PHENYLALANINE HYDROXYLASE ASSAY
The extraction was performed in 0.15 M KC1 (I :20 w/v) using a Branson Sonifier. The tissue was in a plastic Eppendorf tube. which was immersed in an ice-salt mixture. The sonication time was 2 sec with an interval of I min. the procedure being repeated five times. T h e homogenate was transferred to a polyethylene centrifuge tube and centrifuged for 30 min at 40 000 x g i n a Beckman centrifuge with a S W 65 head: the supernatant nuid was used in the assay. The standard assay mixture contained 0.15 M sodium-potassium phosphate (pH 6.9). 2 m M dithioerythritol, 0.1 m M I-phenylalanine. 0.2 wCi ['4C]phenylalanine, I mM lysolecithin. 0.025 mM tetrahydrobiopterin (dissolved in ice-cold 0.005 N HCI and stored frozen), varying amounts of liver extract up to 0.04 ml, and water up to a final volume of 0.2 ml.
The reaction was started with tetrahydrobiopterin as the last component added. One tube contained the complete reaction mixture but with extract which had been boiled before. The mixture was incubated at 25' in a shaking water bath. The reaction was stopped by the addition of 3 M perchloric acid (1:4. v/v). The tubes were then placed in an ice bath for 5 min and centrifuged afterwards.
Aliquots (0.01 ml) of the deproteinized supernatant were applied under a stream of cold air to a cellulose thin layer plate. Tyrosine and phenylalanine standards were spotted on top of each aliquot. The plates were developed for 20 min at room temperature in CHC1,-CH30H-NH,OH-H,O (58:32:8:2, v/v) (15) . After drying in air, the plates were sprayed with a ninhydrin solution. Each plate was scanned. then the areas in which radioactivity was found were scratched off with a razor blade and put in a vial. First I ml water. then 4 ml Unisolve (17) were added. The radioactivity was determined in a liquid scintillation counter.
CALCULATION OF TYROSINE FORMED
The ratio of counts of tyrosine to tyrosine plus phenylalanine was determined and corrected for the counts of boiled enzyme: by multiplication by the phenylalanine input (0.02 pmol/assay) the moles of tyrosine formed per unit time were calculated. This figure was related t o the protein content. Protein was determined 2 5 described by Lowry (14) .
The samples from persons who served as control subjects were gained either during laparatomies performed with cholecystectomy or from needle biopsies performed in children with nonmetabolic liver diseases. Figure 1 shows the interrelation between tyrosine formation and reaction time. Linearity is found up to approximately 20 min , depending on the enzyme concentration, which indicates a substrate limitation. Figure 2 illustrates tyrosine formation when the naturally occurring cofactor. biopterin, was used instead of dimethylpteridine. Biopterin provides optimal conditions in the assay for low residual activities. The use of biopterin implicates the addition of lysolecithin (5) . Preincubation of the enzyme with lysolecithin results in a hyperbolic shape of the time kinetic curve. , Therefore, the simultaneous addition is preferred to avoid this burst.
RESULTS
In Table I Table I ) is quite exceptional in showing no correlation whatever between the usual clinical findings and his hydroxylase activity. He was discovered at 2 weeks of age in the neonatal PKU screening program, showed then a phenylalanine blood level of 46 mg/100 ml and a biochemical response to phenylalanine loading typical for classic PKU. Despite an early start and a good control of the phenylalanine-restricted diet, the patient developed a severe tetraplegia and seems now, at the age of 12 months, to be mentally retarded. At the ages of 6 weeks and 4 months liver needle biopsies were taken. The hydroxylase determinations showed 75.5 and 55.2 pmol tyrosinelg protein x 60 min, respectively, i.e.. low normal values (I).
Even if the clinical picture does not always allow a clear-cut differentiation between patients with no detectable hydroxylase activity and with low residual activity, there should be a difference in their ability to metabolize phenylalanine. The phenylalanine 1 tolerance, i.e., the amount of phenylalanine per kg body weight in I the diet during a long period of well controlled therapy, is two-to threefold higher in patients with low residual activity (Fig. 4 ) compared with patients with no detectable enzyme activity. Only two patients with low residual activity have an unusually low phenylalanine tolerance (cases 23, and 25). They have been observed for a short time only and may still change their phenylalanine tolerance in future months.
DISCUSSION
For reasons of standardization we chose for our phenylalanine hydroxylase assay the constant addition of 2 0 4 supernatant and a reaction time of 60 min. In principle, the assay could be optimized for high hydroxylase activities using higher phenylalanine concentrations and reducing the reaction time to 20 min. Under such Fig. 4 . Phenylalanine tolerance in patients with no detectable enzyme acitivity ( 0 ) and with low residual enzyme activity (0). Each circle stands for a single subject. Tolerance is expressed (along ordinate) as the phenylalanine intake in milligrams per kg body weight ( B W ) per 24 hr which is tolerated with a normal (or near normal) phenylalanine blood level and a normal gain in weight and height.
conditions, however, the relative amounts of tyrosine formed would be reduced when measuring low residual activities, and other technical problems would be increased. Our assay differs from Kaufman's ( I I) in so far as we substitute dithioerythritol for the reductase-dependent tetrahydrobiopterin regenerating system. The catalase needed during the reaction is presumed to be present in the crude extract. The use of tetrahydrobiopterin instead of dimethyltetrahydropteridine is a requisite for low activity determinations (see Fig. 2 ).
In our experience so far no detectable enzyme activity has been correlated consistently with classic P K U except in one instance (case 33; Table I ). The liver biopsy was therefore repeated. with the same result in the assay. That patient was a 3-month-old male. A protein loading test (180 mg phenylalanine/kg body weight for 3 days (2)), did not raise the phenylalanine blood levels beyond 13 mg/100 ml, suggesting a diagnosis of hyperphenylalaninemia rather than PKU. This was further implied by identical loading test results in a 6-year-old brother, who never received treatment and is apparently healthy. Enzyme determination has not been performed in this boy.
Patients with residual enzyme activities merit further discussion, because their exact classification is difficult. Generally patients with high residual activities have phenylalanine blood levels below 10 mg/100 ml on a normal protein intake and are not treated by us. Patients with low residual activity usually are treated; two patients in the lower residual activity group, however, did not receive treatment. Case 22 (Table I ) has been followed by us since her third week of life. She was classified as suffering from mild hyperphenylalaninemia because of phenylalanine blood levels below 10 mg/100 ml. Phenylalanine loading studies were suggestive of this diagnosis. Case 16 (Table I ) was at the time of the biopsy a I-year-old girl who received a phenylalanine-restricted diet for approximately I year because her phenylalanine blood levels exceeded 10 mg/ 100 ml repeatedly. Her increasing phenylalanine tolerance then suggested that the diet might be discontinued, and so far she is doing well on a normal food intake, her phenylalanine blood level not exceeding 10 mg/100 ml. Mental development is proceeding normally in both patients at the ages of 1 and 2 years, respectively.
The observation of some, although very little, residual enzyme activity in cases with classic P K U is interesting. One single pertinent case has been described so far (6) . We believe that we have demonstrated low residual activity in several PKU patients and wish to cite as examples two pairs of brothers. One boy of each pair (cases 14 and 15 ; Table I ) was born before diets restricted in phenylalanine were available, and these patients had to be institutionalized because of severe mental retardation. The other boy of each pair (cases 19 and 20: Table I ) was detected in the neonatal period. received dietetic treatment. and developed normally. These data suggest that such low residual enzyme activities d o not necessarily permit dismissal of the diagnosis of PKU with its therapeutic implications. One could speculate that minimal phenylalanine hydroxylase activity is genetically determined.
The higher residual activity group corresponds to two cases investigated earlier (8) and to the family described by Kang et al. (9) with 31 %. 1090, and 6% of normal activity. In comparing data from different laboratories one has to keep in mind that the assays ~ are different, e.g., dimethyltetrahydropteridine o r tetrahydrobiopterin may be used. As might be anticipated, high residual activity has been found in cases of hyperphenylalaninernia. Our case with practically normal activity despite other biochemical signs of classic PKU is presently being investigated. It is likely that this child suffers from a different molecular defect. Phenylalanine hydroxylase is part of a multienzyme system, so that other defects in this complex system could be anticipated. The large range of hydroxylase rest activities may be compared with the well known molecular genetic variability in galactose-I-phosphate uridyltransferase in galactosemia (3) and glucose-6-phosphate dehydrogenase deficiency (4) .
SUMMARY

I
Using a microenzyme assay on liver needle biopsy specimens, several ranges of phenylalanine hydroxylase activity were found in patients with P K U and hyperphenylalaninemia. No detectable activity is primarily associated with classic PKU. Low residual I activities are not uniformly correlated with P K U or hyperphenylalaninemia. Patients with residual activities of more than 10% of 1 normal seem to have a sufficient phenylalanine tolerance not to be in need of a phenylalanine-restricted diet.
phenylalaninemia irn~tates the metabolic cond~tion at a lower level hut will not, 20. This work was sl~pportrd h) the Deutsche Forschungsgemeinschaft (SFB 35 Unconjugated bilirubin produces toxic effects on mitochondria1 electron transport. oxidative phosphorylation, and ultrastructure (I, I I). Respiratory stimulation and uncoupling are observed at concentrations lower than those necessary to inhibit oxidative phosphorylation (I, 11). Bovine or human serum albumin in vitro prevents injurious effects of bilirubin on isolated mitochondria by preferentially binding the bile pigment (10) .
Ligandin is an abundant cytoplasmic protein found in parenchymal liver cells. proximal tubules of the kidney, and intestinal mucosa, and binds bilirubin and other Iigands. Ligandin is postulated to be an important determinant in the transport of various endogenous and exogenous organic anions (5, 7) .
We have studied the role of ligandin in protecting rat liver mitochondria against effects of bilirubin on respiration and oxidative phosphorylation.
METHODS
Crystalline bilirubin was obtained from Eastman Kodak (12) (E = 60 x lo3 at 450 nm in chloroform). recrystallized. and stored at 0" in the dark. Bilirubin solutions were freshly prepared at concentrations of 10-3-10-' M, 0.02 M aqueous NaOH. and kept at 0" in the dark. Human serum albumin (fraction V, defatted) was obtained from Sigma (13) and prepared in solution at concentrations of 10-3--10-4 M.
Ligandin was purified from Sprague-Dawley rats as described previously (6) . Livers were rapidly removed from male rats (250-350 g) after decapitation and placed in medium containing 0.25 M sucrose, 1.0 mM EDTA, and 10.0 mM Tris-HCI, pH 7.4. The tissue was homogenized with approximately 4 volumes medium using a Potter-Elvehjem glass homogenizer. The homogenate was centrifuged at 800 x g and the supernatant was centrifuged at 13,000 x g. The crude mitochondrial pellet was washed twice in 0.25 M sucrose containing 10 mM Tris-HCI. pH 7.4. Resuspended mitochondria were collected by centrifugation at 25,000 x g. All procedures were performed at 4'. I
Respiration was studied polarographically using a Clarke I oxygen electrode (14) and a specially designed chamber with a column of 1.5 ml. The respiration medium consisted of 0.25 M I sucrose, 5 mM MgCI,. 20 mM potassium phosphate. 10 mM Tris-HCI. pH 7.4 (8) .
RESULTS
Addition of less than 20-30 pm of bilirubin to the mitochondrial medium containing glutamate-malate as a substrate pair increased basal respiration (stare 4 rate). increased phosphorylating respiration (slate 3 rate), and, as shown in Figure I . decreased the respiratory control index (stare 3:4). At higher concentrations of bilirubin, a major decrease of state 3 respiration was observed.
In the presence of human serum albumin, bilirubin effects on srare 3 and 4 respiration were reversed (Fig. 2) . At an equimolar ratio of bilirubin and human serum albumin, the inhibitory effect of bilirubin almost disappeared. As the bilirubin concentration increased, the inhibitory effect of albumin was decreased but was
